4//SEC Filing
ZNM Capital Management, LLC 4
Accession 0001209191-20-064259
CIK 0001703057other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 8:45 PM ET
Size
24.7 KB
Accession
0001209191-20-064259
Insider Transaction Report
Form 4
Bogue Zachary
10% Owner
Transactions
- Conversion
Convertible Note
2020-12-15→ 0 total(indirect: See footnote)Exercise: $17.00→ Common Shares (29,411 underlying) - Conversion
Common Shares
2020-12-15+29,411→ 29,105,761 total(indirect: See footnote) - Conversion
Series A2 Preferred Shares
2020-12-15−802,371→ 0 total(indirect: See footnote)→ Common Shares (8,023,710 underlying) - Conversion
Common Shares
2020-12-15+29,076,350→ 29,076,350 total(indirect: See footnote) - Conversion
Series A1 Preferred Shares
2020-12-15−2,105,264→ 0 total(indirect: See footnote)→ Common Shares (21,052,640 underlying)
DCVC Bio GP, LLC
10% Owner
Transactions
- Conversion
Series A1 Preferred Shares
2020-12-15−2,105,264→ 0 total(indirect: See footnote)→ Common Shares (21,052,640 underlying) - Conversion
Common Shares
2020-12-15+29,411→ 29,105,761 total(indirect: See footnote) - Conversion
Series A2 Preferred Shares
2020-12-15−802,371→ 0 total(indirect: See footnote)→ Common Shares (8,023,710 underlying) - Conversion
Common Shares
2020-12-15+29,076,350→ 29,076,350 total(indirect: See footnote) - Conversion
Convertible Note
2020-12-15→ 0 total(indirect: See footnote)Exercise: $17.00→ Common Shares (29,411 underlying)
JNK Capital Management, LLC
10% Owner
Transactions
- Conversion
Series A1 Preferred Shares
2020-12-15−2,105,264→ 0 total(indirect: See footnote)→ Common Shares (21,052,640 underlying) - Conversion
Series A2 Preferred Shares
2020-12-15−802,371→ 0 total(indirect: See footnote)→ Common Shares (8,023,710 underlying) - Conversion
Common Shares
2020-12-15+29,076,350→ 29,076,350 total(indirect: See footnote) - Conversion
Common Shares
2020-12-15+29,411→ 29,105,761 total(indirect: See footnote) - Conversion
Convertible Note
2020-12-15→ 0 total(indirect: See footnote)Exercise: $17.00→ Common Shares (29,411 underlying)
DCVC Bio, L.P.
10% Owner
Transactions
- Conversion
Series A1 Preferred Shares
2020-12-15−2,105,264→ 0 total(indirect: See footnote)→ Common Shares (21,052,640 underlying) - Conversion
Series A2 Preferred Shares
2020-12-15−802,371→ 0 total(indirect: See footnote)→ Common Shares (8,023,710 underlying) - Conversion
Common Shares
2020-12-15+29,076,350→ 29,076,350 total(indirect: See footnote) - Conversion
Common Shares
2020-12-15+29,411→ 29,105,761 total(indirect: See footnote) - Conversion
Convertible Note
2020-12-15→ 0 total(indirect: See footnote)Exercise: $17.00→ Common Shares (29,411 underlying)
Ocko Matthew
10% Owner
Transactions
- Conversion
Convertible Note
2020-12-15→ 0 total(indirect: See footnote)Exercise: $17.00→ Common Shares (29,411 underlying) - Conversion
Common Shares
2020-12-15+29,411→ 29,105,761 total(indirect: See footnote) - Conversion
Common Shares
2020-12-15+29,076,350→ 29,076,350 total(indirect: See footnote) - Conversion
Series A1 Preferred Shares
2020-12-15−2,105,264→ 0 total(indirect: See footnote)→ Common Shares (21,052,640 underlying) - Conversion
Series A2 Preferred Shares
2020-12-15−802,371→ 0 total(indirect: See footnote)→ Common Shares (8,023,710 underlying)
Stead Kiersten
10% Owner
Transactions
- Conversion
Common Shares
2020-12-15+29,411→ 29,105,761 total(indirect: See footnote) - Conversion
Series A2 Preferred Shares
2020-12-15−802,371→ 0 total(indirect: See footnote)→ Common Shares (8,023,710 underlying) - Conversion
Series A1 Preferred Shares
2020-12-15−2,105,264→ 0 total(indirect: See footnote)→ Common Shares (21,052,640 underlying) - Conversion
Common Shares
2020-12-15+29,076,350→ 29,076,350 total(indirect: See footnote) - Conversion
Convertible Note
2020-12-15→ 0 total(indirect: See footnote)Exercise: $17.00→ Common Shares (29,411 underlying)
ZNM Capital Management, LLC
10% Owner
Transactions
- Conversion
Series A1 Preferred Shares
2020-12-15−2,105,264→ 0 total(indirect: See footnote)→ Common Shares (21,052,640 underlying) - Conversion
Common Shares
2020-12-15+29,076,350→ 29,076,350 total(indirect: See footnote) - Conversion
Convertible Note
2020-12-15→ 0 total(indirect: See footnote)Exercise: $17.00→ Common Shares (29,411 underlying) - Conversion
Series A2 Preferred Shares
2020-12-15−802,371→ 0 total(indirect: See footnote)→ Common Shares (8,023,710 underlying) - Conversion
Common Shares
2020-12-15+29,411→ 29,105,761 total(indirect: See footnote)
Footnotes (4)
- [F1]The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the "Preferred Shares") were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering ("IPO"). The Preferred Shares converted into Common Shares at a 1:10 ratio upon the closing of the IPO without payment of additional consideration. The Preferred Shares had no expiration date.
- [F2]These securities are held by DCVC Bio, L.P. ("DCVC Bio"). DCVC Bio GP, LLC ("DCVC Bio GP") is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC ("JNK") and ZNM Capital Management, LLC ("ZNM") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio.
- [F3](Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any.
- [F4]The convertible promissory note ("Convertible Note") had a maturity date of October 30, 2025 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001836103
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 8:45 PM ET
- Size
- 24.7 KB